Cashu | News | DRRX

HomeWatchlistNewsSignalsPicks

DJI

-0.48%

SPX

-0.32%

IXIC

-0.03%

FTSE

-0.09%

N225

+1.03%

AXJO

+0.51%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Durect News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders

Feature Image for interests on Financial Services, Halper Sadeh Llp, Healthcare, Stock from prnewswire.com

Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout

Feature Image for interests on Biotech, Healthcare, Industrials, Large Cap from benzinga.com

about 1 month ago

12 Health Care Stocks Moving In Tuesday's Intraday Session

about 1 month ago

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

about 1 month ago

12 Health Care Stocks Moving In Friday's Pre-Market Session

finance.yahoo.com

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference

Feature Image for interests on Ah, Biopharmaceutical Company, Clinical Development, Drug Candidate from finance.yahoo.com

about 1 year ago

finance.yahoo.com

KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer

Feature Image for interests on Avalo Therapeutics, Biotech Company, Clinical Development, Corporate Finance from finance.yahoo.com

about 1 year ago

businesswire.com

KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer

Feature Image for interests on ETF, Financial Services, Healthcare, Stock from businesswire.com

about 1 year ago

finance.yahoo.com

DURECT Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Feature Image for interests on Analyst Estimates, Durect, Earnings Per Share, Healthcare from finance.yahoo.com

about 1 year ago

finance.yahoo.com

DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update

Feature Image for interests on Biopharmaceutical Company, Durect, Financial Results, Healthcare from finance.yahoo.com

about 1 year ago

Stocks

Health Care

drrx

Durect

NASDAQ: DRRX

+0.02 (+0.79%)

1.925

USD

At close at Sep 05, 20:35 UTC

Latest Cashu News

Durect Under Legal Scrutiny Amid Acquisition Talks with Bausch Health Companies

Bausch Health Acquires DURECT to Enhance Therapeutic Portfolio with Innovative Solutions

about 1 month ago

Bausch Health Acquires DURECT to Enhance Therapeutic Portfolio and Drive Innovation

about 1 month ago